Eagle Pharmaceuticals, Inc. (EGRX)
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
$55.45M
Mr. Scott L. Tarriff
114.00
Woodcliff Lake, NJ
Feb 12, 2014
5.02
$0.85
0.18
2.16
18.82%
8.33%
5.31
0.05
0.23
0.44
1.67
2.70%
4.41%
Similar stocks (7)
Prestige Consumer Healthcare Inc.
PBH
Amphastar Pharmaceuticals, Inc.
AMPH
ANI Pharmaceuticals, Inc.
ANIP
Collegium Pharmaceutical, Inc.
COLL
Evolus, Inc.
EOLS
Phibro Animal Health Corporation
PAHC
Silver Spike Investment Corp.
SSIC
ETF Exposure (17)
ETC 6 Meridian Small Cap Equity ETF
SIXS
1.27%
ETC 6 Meridian Low Beta Equity Strategy ETF
SIXL
0.44%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.015%
iShares Micro-Cap ETF
IWC
0.01201%
Schwab U.S. Small-Cap ETF
SCHA
0.0015237192%
iShares MSCI USA Small-Cap Multifactor ETF
SMLF
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (7)
Prestige Consumer Healthcare Inc.
PBH
Amphastar Pharmaceuticals, Inc.
AMPH
ANI Pharmaceuticals, Inc.
ANIP
Collegium Pharmaceutical, Inc.
COLL
Evolus, Inc.
EOLS
Phibro Animal Health Corporation
PAHC
Silver Spike Investment Corp.
SSIC
ETF Exposure (17)
ETC 6 Meridian Small Cap Equity ETF
SIXS
1.27%
ETC 6 Meridian Low Beta Equity Strategy ETF
SIXL
0.44%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.015%
iShares Micro-Cap ETF
IWC
0.01201%
Schwab U.S. Small-Cap ETF
SCHA
0.0015237192%
iShares MSCI USA Small-Cap Multifactor ETF
SMLF
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%